Clinical value and survival analysis of subcutaneous soft tissue metastasis detected by 18F-FDG PET/CT

ObjectiveTo retrospectively analyze cases of whole-body 18F-FDG PET/CT imaging, identify abnormal images of subcutaneous nodules, and explore the clinical application value of PET/CT in detecting subcutaneous soft tissue metastases and its impact on survival.MethodAn analysis was conducted on cases...

Full description

Saved in:
Bibliographic Details
Main Authors: Yufei Gao, Hui Zhang, Tiancheng Hao, Lizhuo Jia, Jiangmeng Wu, Dongxue Wu, Siqi Wu, Yong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1561137/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849704486840303616
author Yufei Gao
Hui Zhang
Tiancheng Hao
Lizhuo Jia
Jiangmeng Wu
Dongxue Wu
Siqi Wu
Yong Wang
author_facet Yufei Gao
Hui Zhang
Tiancheng Hao
Lizhuo Jia
Jiangmeng Wu
Dongxue Wu
Siqi Wu
Yong Wang
author_sort Yufei Gao
collection DOAJ
description ObjectiveTo retrospectively analyze cases of whole-body 18F-FDG PET/CT imaging, identify abnormal images of subcutaneous nodules, and explore the clinical application value of PET/CT in detecting subcutaneous soft tissue metastases and its impact on survival.MethodAn analysis was conducted on cases from August 2019 to August 2024, and 57 cases of subcutaneous nodules were found to have positive 18F-FDG imaging, all of which underwent pathological puncture or biopsy. Collect patient histological subtypes, metastasis patterns, treatment, and survival rates. Kaplan Meier curves were used to estimate survival time, and Mantel-Cox univariate analysis was used to determine the correlation between extensive metastasis, degree of soft tissue involvement, systemic and local treatment, and survival time.ResultAmong the 57 patients confirmed by pathology, 10 were benign and 47 were malignant. Among 47 cases of malignant tumors, 39 cases were postoperative cases, 8 cases were preoperative cases, and 4 cases had unknown primary lesions. A total of 88 subcutaneous lesions were found, including 28 patients with a single lesion, 12 patients with two lesions, and 8 patients with three or more lesions. One patient with unknown primary lesion reported abdominal wall nodules as the main symptom. PET/CT assisted in qualitative localization in 11 cases. Univariate analysis showed that the median survival time (22 months) of patients who did not receive local radiotherapy was significantly shorter than that of patients who did receive local radiotherapy (60 months) (P<0.05). There is no correlation between gender, metastasis pattern, metastasis at initial diagnosis, use of chemotherapy, and survival time.ConclusionWhole body PET/CT imaging has important application value in the diagnosis of subcutaneous soft tissue metastasis. By comprehensively evaluating the patient’s overall condition and accurately determining whether there is a simple soft tissue metastasis, local intervention measures can bring more favorable prognosis for patients with good general condition and only soft tissue metastasis.
format Article
id doaj-art-50a3627878004bbead32f66c8aefbe82
institution DOAJ
issn 2234-943X
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-50a3627878004bbead32f66c8aefbe822025-08-20T03:16:45ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-04-011510.3389/fonc.2025.15611371561137Clinical value and survival analysis of subcutaneous soft tissue metastasis detected by 18F-FDG PET/CTYufei Gao0Hui Zhang1Tiancheng Hao2Lizhuo Jia3Jiangmeng Wu4Dongxue Wu5Siqi Wu6Yong Wang7Department of Radiology and Nuclear Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Medical Imaging, Hebei General Hospital, Shijiazhuang, Hebei, ChinaDepartment of Radiology and Nuclear Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Radiology and Nuclear Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Radiology and Nuclear Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Radiology and Nuclear Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Radiology and Nuclear Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Radiology and Nuclear Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, ChinaObjectiveTo retrospectively analyze cases of whole-body 18F-FDG PET/CT imaging, identify abnormal images of subcutaneous nodules, and explore the clinical application value of PET/CT in detecting subcutaneous soft tissue metastases and its impact on survival.MethodAn analysis was conducted on cases from August 2019 to August 2024, and 57 cases of subcutaneous nodules were found to have positive 18F-FDG imaging, all of which underwent pathological puncture or biopsy. Collect patient histological subtypes, metastasis patterns, treatment, and survival rates. Kaplan Meier curves were used to estimate survival time, and Mantel-Cox univariate analysis was used to determine the correlation between extensive metastasis, degree of soft tissue involvement, systemic and local treatment, and survival time.ResultAmong the 57 patients confirmed by pathology, 10 were benign and 47 were malignant. Among 47 cases of malignant tumors, 39 cases were postoperative cases, 8 cases were preoperative cases, and 4 cases had unknown primary lesions. A total of 88 subcutaneous lesions were found, including 28 patients with a single lesion, 12 patients with two lesions, and 8 patients with three or more lesions. One patient with unknown primary lesion reported abdominal wall nodules as the main symptom. PET/CT assisted in qualitative localization in 11 cases. Univariate analysis showed that the median survival time (22 months) of patients who did not receive local radiotherapy was significantly shorter than that of patients who did receive local radiotherapy (60 months) (P<0.05). There is no correlation between gender, metastasis pattern, metastasis at initial diagnosis, use of chemotherapy, and survival time.ConclusionWhole body PET/CT imaging has important application value in the diagnosis of subcutaneous soft tissue metastasis. By comprehensively evaluating the patient’s overall condition and accurately determining whether there is a simple soft tissue metastasis, local intervention measures can bring more favorable prognosis for patients with good general condition and only soft tissue metastasis.https://www.frontiersin.org/articles/10.3389/fonc.2025.1561137/fulltransfersubcutaneous soft tissuePET/CTsurvival analysismalignant tumor
spellingShingle Yufei Gao
Hui Zhang
Tiancheng Hao
Lizhuo Jia
Jiangmeng Wu
Dongxue Wu
Siqi Wu
Yong Wang
Clinical value and survival analysis of subcutaneous soft tissue metastasis detected by 18F-FDG PET/CT
Frontiers in Oncology
transfer
subcutaneous soft tissue
PET/CT
survival analysis
malignant tumor
title Clinical value and survival analysis of subcutaneous soft tissue metastasis detected by 18F-FDG PET/CT
title_full Clinical value and survival analysis of subcutaneous soft tissue metastasis detected by 18F-FDG PET/CT
title_fullStr Clinical value and survival analysis of subcutaneous soft tissue metastasis detected by 18F-FDG PET/CT
title_full_unstemmed Clinical value and survival analysis of subcutaneous soft tissue metastasis detected by 18F-FDG PET/CT
title_short Clinical value and survival analysis of subcutaneous soft tissue metastasis detected by 18F-FDG PET/CT
title_sort clinical value and survival analysis of subcutaneous soft tissue metastasis detected by 18f fdg pet ct
topic transfer
subcutaneous soft tissue
PET/CT
survival analysis
malignant tumor
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1561137/full
work_keys_str_mv AT yufeigao clinicalvalueandsurvivalanalysisofsubcutaneoussofttissuemetastasisdetectedby18ffdgpetct
AT huizhang clinicalvalueandsurvivalanalysisofsubcutaneoussofttissuemetastasisdetectedby18ffdgpetct
AT tianchenghao clinicalvalueandsurvivalanalysisofsubcutaneoussofttissuemetastasisdetectedby18ffdgpetct
AT lizhuojia clinicalvalueandsurvivalanalysisofsubcutaneoussofttissuemetastasisdetectedby18ffdgpetct
AT jiangmengwu clinicalvalueandsurvivalanalysisofsubcutaneoussofttissuemetastasisdetectedby18ffdgpetct
AT dongxuewu clinicalvalueandsurvivalanalysisofsubcutaneoussofttissuemetastasisdetectedby18ffdgpetct
AT siqiwu clinicalvalueandsurvivalanalysisofsubcutaneoussofttissuemetastasisdetectedby18ffdgpetct
AT yongwang clinicalvalueandsurvivalanalysisofsubcutaneoussofttissuemetastasisdetectedby18ffdgpetct